Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis

Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis

Background: Programmed death-ligand 1 (PD-L1) is an immune checkpoint molecule expressed by cancer cells. Previous studies have demonstrated the prognostic role of PD-L1 expression in patients with small cell lung cancer (SCLC), where the results were inconsistent. Therefore, we conducted a meta-ana...

Full description

Bibliographic Details
Main Authors: Huarong Cai, Haimei Zhang, Yuequan Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Oncology
Subjects:
PD-L1
SCLC
meta-analysis
immunotherapy
risk factor
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01079/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01079/full

Similar Items